Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer: A Systematic Review with Meta-Analysis
Publication in refereed journal


Times Cited
Web of Science25WOS source URL (as at 29/05/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractBackground: This study aims to comprehensively summarize the currently available evidences on the efficacy and safety of gemcitabine plus erlotinib for treating advanced pancreatic cancer.
All Author(s) ListYang ZY, Yuan JQ, Di MY, Zheng DY, Chen JZ, Ding H, Wu XY, Huang YF, Mao C, Tang JL
Journal namePLoS ONE
Year2013
Month3
Day5
Volume Number8
Issue Number3
PublisherPUBLIC LIBRARY SCIENCE
ISSN1932-6203
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesMultidisciplinary Sciences; MULTIDISCIPLINARY SCIENCES; Science & Technology - Other Topics

Last updated on 2020-29-05 at 23:21